Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams and Wilkins
Abstract
Combined antiretroviral therapy (cART) increased the life expectancy of people living with Human Immunodeficiency Virus (HIV) (PLHIV) and remarkably reduced the morbidity and mortality associated with HIV infection. Consequently, PLHIV are experiencing non-acquired immunodeficiency syndrome (AIDS) associated comorbid conditions including diabetes, hyperlipidemia, hypertension, and cardiovascular disease. The aim of this study is to determine the frequency of non-AIDS associated comorbid conditions among a cohort of PLHIV on cART in Lebanon. Data were collected between November 2018 and December 2019 from 105 voluntary participants. A standardized questionnaire was used to collect demographic and behavioral data including lifestyle, smoking, physical activity, substance use and abuse in addition to co-infections and family history of non-communicable diseases. Moreover, data on occurrence and treatment of cardiovascular disease, hypertension, diabetes, lipid and metabolic disorders as well as mental health were collected. Blood samples were used to assess the levels of fasting blood sugar (FBS), glycosylated hemoglobin (HbA1C), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein, total cholesterol, and serum creatinine. Hypertension (29.5%) and hyperlipidemia (29.5%) followed by diabetes (23.7%) and cardiovascular disease (9.7%) were mainly reported among study participants. Higher rate of comorbid conditions was observed among participants >40 years of age than those ≤40 years with both hypertension and hyperlipidemia most commonly reported. Older age (odds ratio [OR] 7.6; 95% CI: 1.83-31.98; P = .005) is associated with higher odds of having hyperlipidemia. Moreover, participants on cART for ≥10 years are 5 times more likely to have hyperlipidemia (OR 5; 95% CI: 1.08-22.73; P = .039). Our results also showed that study participants did not experience anxiety, depression or somatic symptoms and that there was no association between these mental disorders and older age or comorbidities. Our results provide important information on HIV trends and associated comorbidities in Lebanon and can be used to improve the management of non-communicable diseases among PLHIV. © 2022 Lippincott Williams and Wilkins. All rights reserved.
Description
Keywords
Aging, Comorbidity, Haart, Hiv, Lebanon, Adult, Cardiovascular diseases, Diabetes mellitus, Hiv infections, Humans, Hypertension, Noncommunicable diseases, Anti human immunodeficiency virus agent, Glucose, Hemoglobin a1c, High density lipoprotein, Human immunodeficiency virus proteinase inhibitor, Lipid, Low density lipoprotein, Nonnucleoside reverse transcriptase inhibitor, Nucleoside nucleotide reverse transcriptase inhibitor, Triacylglycerol, Unclassified drug, Antiretroviral therapy, Anxiety, Article, Blood sampling, Cardiovascular disease, Cholesterol blood level, Coinfection, Creatinine blood level, Demography, Depression, Family history, Fasting, Female, Glucose blood level, Human, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection, Human tissue, Hyperlipidemia, Lifestyle, Major clinical study, Male, Metabolic disorder, Middle aged, Non communicable disease, Odds ratio, Physical activity, Questionnaire, Smoking, Sociodemographics, Substance abuse, Substance use, Trend study, Complication